Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Detailed results from Novo's trial testing the higher dose of Wegovy, which contains the active ingredient semaglutide, are expected to be presented at a scientific conference in 2025, according ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click ...

Its use was limited to type 2 diabetes. The big drug of the moment is semaglutide, marketed in slightly different formulations under a range of brand names, including Ozempic and Wegovy.

With Victoza already approved and semaglutide under development, Novo Nordisk is one of several companies that have pioneered the use of GLP-1 class drugs to help control blood sugar in type 2 ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

He noted that the main call to action for the medical questionnaire was hidden under the several products that Roman was pushing at the top of the page. Aaron was also surprised by the way the ...